Although detailed information about individual endocrine therapy was absent, as most hormone receptor positive BC patients will receive endocrine therapy and the evidence listed above, our study implies some inhibitory effect of endocrine therapy on lung cancer carcinogenesis and progression. The gene discussed is NR4A1; the disease is lung cancer.